Paper29731990
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.
Moro K and 8 others. Oncotarget, 2018. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. Papers, record 29731990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29731990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016059 | NCI NIH HHS | United States | P30CA016059 | PubMed and NIH | NIH RePORTER |
| R01 CA160688 | NCI NIH HHS | United States | R01CA160688 | PubMed and NIH | NIH RePORTER |
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20110355 | Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20110355 | PubMed |
| 2 | 24453046 | Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell. | J Cell Biochem | 2014 | https://conductscience.org/library/papers/24453046 | PubMed |
| 3 | 26296077 | GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. | Mov Disord | 2016 | https://conductscience.org/library/papers/26296077 | PubMed |
| 4 | 21460633 | FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. | Autophagy | 2011 | https://conductscience.org/library/papers/21460633 | PubMed |
| 5 | 17560328 | A CERTain role for ceramide in taxane-induced cell death. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17560328 | PubMed |
| 6 | 20137073 | Ceramide and ceramide 1-phosphate in health and disease. | Lipids Health Dis | 2010 | https://conductscience.org/library/papers/20137073 | PubMed |
| 7 | 29147025 | Sphingolipid metabolism in cancer signalling and therapy. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29147025 | PubMed |
| 8 | 9698369 | Purification and characterization of ceramide-activated protein phosphatases. | Biochemistry | 1998 | https://conductscience.org/library/papers/9698369 | PubMed |
| 9 | 25634657 | Ceramide induced mitophagy and tumor suppression. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25634657 | PubMed |
| 10 | 29313949 | Cancer statistics, 2018. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/29313949 | PubMed |
| 11 | 23863933 | Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids. | Nature | 2013 | https://conductscience.org/library/papers/23863933 | PubMed |
| 12 | 19729656 | Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. | Science | 2009 | https://conductscience.org/library/papers/19729656 | PubMed |
| 13 | 27565080 | High levels of sphingolipids in human breast cancer. | J Surg Res | 2016 | https://conductscience.org/library/papers/27565080 | PubMed |
| 14 | 28357533 | Increased ceramide production sensitizes breast cancer cell response to chemotherapy. | Cancer Chemother Pharmacol | 2017 | https://conductscience.org/library/papers/28357533 | PubMed |
| 15 | 24457089 | 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. | Bioorg Med Chem | 2014 | https://conductscience.org/library/papers/24457089 | PubMed |
| 16 | 24422988 | Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24422988 | PubMed |
| 17 | 8662781 | Ceramide inactivates cellular protein kinase Calpha. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8662781 | PubMed |
| 18 | 23273921 | Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | Cancer Cell | 2013 | https://conductscience.org/library/papers/23273921 | PubMed |
| 19 | 29370930 | Expression of phosphorylated sphingosine kinase 1 is associated with diffuse type and lymphatic invasion in human gastric cancer. | Surgery | 2018 | https://conductscience.org/library/papers/29370930 | PubMed |
| 20 | 29269995 | The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer. | Mediators Inflamm | 2017 | https://conductscience.org/library/papers/29269995 | PubMed |
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41323506 | Unsupervised Random Forest Identifies Important Genetic Prognostic Factors for Breast Cancer Survival Time. | Cancer Inform | 2025 | https://conductscience.org/library/papers/41323506 | PubMed |
| 40429618 | Differential Effects of Sphingolipids on Cell Death and Antioxidant Defenses in Type 1 and Type 2 Endometrial Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429618 | PubMed |
| 40384804 | Therapeutic Potential of Ceramide in Cancer Treatment. | J Cancer Res Oncobiol | 2024 | https://conductscience.org/library/papers/40384804 | PubMed |
| 40137159 | Ceramide as a Promising Tool for Diagnosis and Treatment of Clinical Diseases: A Review of Recent Advances. | Metabolites | 2025 | https://conductscience.org/library/papers/40137159 | PubMed |
| 40088396 | Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/40088396 | PubMed |
| 39767566 | Diagnostics and Therapy for Malignant Tumors. | Biomedicines | 2024 | https://conductscience.org/library/papers/39767566 | PubMed |
| 39691590 | Monitoring concentration and lipid signature of plasma extracellular vesicles from HR+ metastatic breast cancer patients under CDK4/6 inhibitors treatment. | J Extracell Biol | 2024 | https://conductscience.org/library/papers/39691590 | PubMed |
| 39452927 | Detection and Validation of Organic Metabolites in Urine for Clear Cell Renal Cell Carcinoma Diagnosis. | Metabolites | 2024 | https://conductscience.org/library/papers/39452927 | PubMed |
| 39408574 | The Interplay between Oxidative Stress and Sphingolipid Metabolism in Endometrial Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408574 | PubMed |
| 38542328 | Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542328 | PubMed |
| 38425919 | Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy. | JACS Au | 2024 | https://conductscience.org/library/papers/38425919 | PubMed |
| 37869237 | Oral Administration of Glucosylceramide Suppresses Tumor Growth by Affecting the Ceramide/Sphingosine-1-Phosphate Balance in Breast Cancer Tissue. | World J Oncol | 2023 | https://conductscience.org/library/papers/37869237 | PubMed |
| 37760612 | Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760612 | PubMed |
| 37446046 | Diverse Sphingolipid Profiles in Rectal and Colon Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446046 | PubMed |
| 37190166 | Lipidomic Profiling Reveals Biological Differences between Tumors of Self-Identified African Americans and Non-Hispanic Whites with Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190166 | PubMed |
| 37163537 | Lipidomics-based tissue heterogeneity in specimens of luminal breast cancer revealed by clustering analysis of mass spectrometry imaging: A preliminary study. | PLoS One | 2023 | https://conductscience.org/library/papers/37163537 | PubMed |
| 36860848 | Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/36860848 | PubMed |
| 36768427 | The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768427 | PubMed |
| 36630049 | Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma. | Cell Oncol (Dordr) | 2023 | https://conductscience.org/library/papers/36630049 | PubMed |
| 36541910 | Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer. | Cancer Res | 2023 | https://conductscience.org/library/papers/36541910 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29731990
GET https://conductscience.org/api/papers/v1/29731990/references?page=2